Clinical Trial Update: Efficacy and Optimal Dose Selection of Intranasal Dexmedetomidine During Breast Lumpectomy Under Local Anaesthesia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and optimal dose of intranasal dexmedetomidine during breast lumpectomy under local anesthesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dexmedetomidine (intranasal) (dexmedetomidine)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Intranasal Dexmedetomidine Breast Cancer Local Anaesthesia | Phase 2 | Status: COMPLETED